Cited by 149Cancer-related Molecular PathwaysGenomics and Chromatin DynamicsEvolution and Genetic Dynamics

Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity

Open access
Resnick, Michael A., Inga, Alberto·2003·Proceedings of the National Academy of Sciences

Abstract

There are many sources of genetic diversity, ranging from programmed mutagenesis in antibody genes to random mutagenesis during species evolution or development of cancer. We propose that mutations in DNA sequence-specific transcription factors that target response elements (REs) in many genes can also provide for rapid and broad phenotypic diversity, if the mutations lead to altered binding affinities at individual REs. To test this concept, we examined the in vivo transactivation capacity of wild-type human and murine p53 and 25 partial function mutants. The p53s were expressed in yeast from a rheostatable promoter, and the transactivation capacities toward >15 promoter REs upstream of a reporter gene were measured. Surprisingly, there was wide variation in transactivation by the mutant p53s toward the various REs. This is the first study to address directly the impact of mutations in a sequence-specific transcription factor on transactivation from a wide array of REs. We propose a master gene hypothesis for phenotypic diversity where the master gene is a single transcriptional activator (or repressor) that regulates many genes through different REs. Mutations of the master gene can lead to a variety of simultaneous changes in both the selection of targets and the extent of transcriptional modulation at the individual targets, resulting in a vast number of potential phenotypes that can be created with minimal mutational changes without altering existing protein-protein inte…

Integrity signals

Registry

Crossref · 10.1073/pnas.1633803100

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many tumor-associated p53 mutants exhibit change-of-spectrum transactivation from various p53 targets.

    “Since many tumor-associated p53 mutants exhibit change-of-spectrum transactivation from various p53 targets, we examined the ability of twenty-five p53 mutants to activate endogenous expression of the TLR gene family in p53 null human cancer cell lines following transfection with p53 mutant expression vectors.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Resnick, M. A., & Inga, A.
Affiliations
National Institutes of Health (US)
Venue
Proceedings of the National Academy of Sciences
Published
2003-08-08
Volume
100
Issue
17
Pages
9934-9939
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2042075518
Cited by
149
References
6
Citations by year
2024: 3 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 2 · 2016: 6 · 2015: 3 · 2014: 7 · 2013: 5 · 2012: 10
FWCI
5.38
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Iris (University of Trento) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
p53, sequence-specific transcription factors, transcriptional activation, response elements, phenotypic diversity, transcriptional regulation, protein-DNA binding affinity, genetic diversity
MeSH terms
Animals, DNA, Humans, Models, Genetic, Mutation, Phenotype, Promoter Regions, Genetic, Saccharomyces cerevisiae, Transcription Factors, Genetic Variation, Transcriptional Activation, Genes, p53, Tumor Suppressor Protein p53, Genes, Reporter, Evolution, Molecular, Amino Acid Substitution, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review